RNA-Targeted Drug Approved for Preventing Hereditary Angioedema Attacks

abdulmanannet77@gmail.comAugust 21, 2025

0 0 Less than a minute

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

RNA-Targeted Drug Approved for Preventing Hereditary Angioedema Attacks (MedPage Today) — Donidalorsen (Dawnzera) received FDA approval for prophylactic treatment of hereditary angioedema (HAE) in adults and kids 12 years and older, Ionis Pharmaceuticals announced on Thursday.
The RNA-targeted therapy, a first for…